BioPharma Dive Dec 8, 2025 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive Dec 8, 2025 Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
BioPharma Dive Dec 5, 2025 Hemophilia gene therapies are struggling on the market, even as innovation soars
BioPharma Dive Dec 3, 2025 After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis